Incumbency footprint / loaded awards
AURAVAX THERAPEUTICS, INC.
Source set: USASpending · As of 2026-11-10. Coverage is limited to loaded award records.
UEI as published: PAN3ZK2YLAL2
Active-award and obligated rollups are withheld: the agent-written rollup has no covered period or n field. A full federal footprint is not verified.
Loaded award records
| Incumbent / award | Agency | Obligated | Source end date | Provenance |
|---|---|---|---|---|
| AURAVAX THERAPEUTICS, INC.75A50124C00054 ↗ | Department of Health and Human Services | $749,999.00 | 2027-07-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_75A50124C00054_7505_-NONE-_-NONE-As of 2026-09-30 |
Upcoming source end dates
| Incumbent / award | Agency | Obligated | Source end date | Provenance |
|---|---|---|---|---|
| AURAVAX THERAPEUTICS, INC.75A50124C00054 ↗ | Department of Health and Human Services | $749,999.00 | 2027-07-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_75A50124C00054_7505_-NONE-_-NONE-As of 2026-09-30 |
Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.